Zevia PBC (NYSE:ZVIA) Issues Quarterly Earnings Results

Zevia PBC (NYSE:ZVIA) announced its quarterly earnings data on Wednesday. The company reported ($0.03) EPS for the quarter, hitting analysts’ consensus estimates of ($0.03), Zacks reports. Zevia PBC had a negative return on equity of 16.70% and a negative net margin of 5.34%.The company had revenue of $45.00 million during the quarter, compared to the consensus estimate of $44.21 million.

Here are the key takeaways from Zevia PBC’s conference call:

• Second-quarter results exceeded expectations, with net sales up 1.1% to $45 million and adjusted EBITDA of approximately $0.5 million. First-half sales rose 10.4% to $91.1 million, while adjusted EBITDA improved by $4.5 million year over year.
• Management identified singles as Zevia’s most significant growth opportunity, citing limited current penetration and potential to expand household trial. A new go-to-market strategy covering distribution and in-store execution is being developed for implementation beginning in early 2027.
• Zevia expects third-quarter adjusted EBITDA loss of $3 million to $3.5 million and gross margin of roughly 46%, pressured by higher aluminum and fuel costs, promotions, channel mix, and increased marketing investment. The company maintained full-year adjusted EBITDA guidance of a $2 million to $4 million loss.
• The Cardi B “Refreshingly Real” campaign generated substantial early engagement, including nearly 29.5 billion social video views and 1.8 billion earned-media impressions. Initial readings for the new packaging and flavors were also positive in the natural channel, although management said it is too early to assess sustained sales impact.
• Zevia maintained full-year 2026 net sales guidance of $170 million to $175 million, despite discontinuing its tea offering. Management expects $3 million to $5 million of additional cost savings beginning in the first quarter of 2027.

Zevia PBC Stock Down 1.4%

ZVIA traded down $0.02 during trading hours on Friday, hitting $1.45. 204,309 shares of the company’s stock were exchanged, compared to its average volume of 864,134. The stock’s 50-day moving average is $1.57 and its two-hundred day moving average is $1.49. Zevia PBC has a 1-year low of $1.11 and a 1-year high of $3.54. The stock has a market cap of $111.62 million, a price-to-earnings ratio of -11.15 and a beta of 0.99.

Insiders Place Their Bets

In other Zevia PBC news, major shareholder De Depot Et Placement D. Caisse sold 2,150,000 shares of Zevia PBC stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $1.90, for a total transaction of $4,085,000.00. Following the completion of the transaction, the insider directly owned 11,400,428 shares of the company’s stock, valued at $21,660,813.20. The trade was a 15.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 7.70% of the company’s stock.

Institutional Investors Weigh In On Zevia PBC

Hedge funds have recently bought and sold shares of the stock. Bank of America Corp DE increased its stake in shares of Zevia PBC by 2,845.4% during the fourth quarter. Bank of America Corp DE now owns 15,817 shares of the company’s stock worth $66,000 after purchasing an additional 15,280 shares during the period. Cubist Systematic Strategies LLC raised its position in shares of Zevia PBC by 52.7% in the first quarter. Cubist Systematic Strategies LLC now owns 79,275 shares of the company’s stock valued at $171,000 after buying an additional 27,343 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of Zevia PBC in the first quarter valued at approximately $187,000. Geode Capital Management LLC raised its holdings in Zevia PBC by 66.5% in the 2nd quarter. Geode Capital Management LLC now owns 933,407 shares of the company’s stock valued at $3,006,000 after acquiring an additional 372,665 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in shares of Zevia PBC by 2,460.7% during the 2nd quarter. JPMorgan Chase & Co. now owns 15,518 shares of the company’s stock worth $50,000 after purchasing an additional 14,912 shares in the last quarter. 53.21% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Zevia PBC from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, July 17th. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $3.90.

About Zevia PBC

Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.

The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.